02Aug
FDA Issues Cannabidiol Marketing Warning as Congressional Pressure for Action Continues
Following through with its promise to take enforcement actions against companies marketing cannabis-derived products that could put consumers at risk, the Food and Drug Administration (FDA) recently issued a warning letter to Curaleaf Inc., a...
By:
Wilson Sonsini Goodrich & Rosati
Related
Noori v. Countrywide Payroll & HR Solutions, Inc., 2019 WL 7183403 (Cal. Ct. App. 2019) - Mohammed...
Read More >
Following the prime minister’s announcement that free movement will come to an end, the UK governme...
Read More >
When I left my last job as a lawyer, I was Of Counsel and on a good trajectory. I had carefully buil...
Read More >
Main contractors often make claims against subcontractors for liquidated damages for delay. A questi...
Read More >
Force majeure provisions are top of mind for many businesses today because of the pandemic of SARS-...
Read More >
The recently updated Construction Contractors Technical Assistance Guide (“TAG”) provides construc...
Read More >